Director, SYFOVRE Market Access Strategy

About the role

Opportunity awaits those up to the challenge of developing transformative therapies across a broad range of debilitating diseases. The Director, SYFOVRE Market Access Strategy will lead the U.S. market access strategy for SYFOVRE, with responsibility for optimizing pricing, contracting, and payer/reimbursement marketing in the evolving retina marketplace. Reporting to the Head of Access Strategy for Retina and Nephrology/Hematology, this role will manage a team focused on payer and reimbursement marketing strategy and tactics, pricing and contracting initiatives, and support for payer, strategic accounts, and reimbursement field teams. As the senior market access lead for SYFOVRE, you will be ultimately accountable to the BNA Leadership Team for integrated access strategy and performance. You will lead a multidisciplinary team and partner across MA&R, Medical, Finance, Trade & Distribution, and the SYFOVRE franchise to anticipate market changes, address access barriers, and ensure access strategy is integrated with brand objectives. This is a hybrid role with approximately 10% travel.

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit http://apellis.com or follow us on LinkedIn and X.

Responsibilities

• Lead the integrated U.S. market access strategy for SYFOVRE and serve as the single point of accountability to the BNA Leadership Team for access performance, risks, and required actions.
• Lead pricing and contracting strategies that balance patient access, provider economics, competitive positioning, and sustainable net revenue.
• Lead payer and reimbursement marketing and optimize the buy-and-bill experience across coverage, coding, payment, acquisition economics, and operational barriers.
• Monitor evolving retina market dynamics, including competitive products, biosimilars, payer utilization management, provider economics,